| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bioxcel Therapeutics, Inc. (BTAI) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. BTAI is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 17.0K | $20.2K | - | |
| Dir | 17.0K | $20.2K | - | |
| Dir | 17.0K | $20.2K | - | |
| Dir | 17.0K | $20.2K | - | |
| Dir | 17.0K | $20.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 22, 2023 | Mehta Vimal92 | CEO And President | Sell | 6,500 | $25.79 | $167,640.85 | -14.8% | -84.7% | -92.2% | |
| May 15, 2023 | Steinhart Richard I87 | Chief Financial Officer | Sale+OE | 5,000 | $27.17 | $135,863.50 | -76.9% | -84.1% | -92.2% | |
| May 15, 2023 | Rodriguez Javier87 | See Remarks | Sale+OE | 1,785 | $27.32 | $48,764.77 | -29.1% | -84.1% | -92.2% | |
| Apr 6, 2023 | Nandabalan Krishnan75 | Director, 10% Owner | Sale+OE | 60,000 | $17.32 | $1,039,200.00 | -100% | -35.1% | -84.6% | |
| Mar 21, 2023 | Mehta Vimal92 | CEO And President | Sale+OE | 64,500 | $18.97 | $1,223,313.42 | -36.7% | +2.6% | -85.6% | |
| Mar 15, 2023 | Steinhart Richard I87 | Chief Financial Officer | Sale+OE | 2,084 | $19.50 | $40,638.00 | -58.1% | +2.8% | -85.4% | |
| Mar 15, 2023 | Yocca Frank88 | Chief Scientific Officer | Sale+OE | 985 | $19.69 | $19,395.73 | -9.4% | +2.8% | -85.4% | |
| Mar 15, 2023 | O'Neill Vincent86 | Chief Medical Officer | Sale+OE | 845 | $19.70 | $16,642.28 | -40.5% | +2.8% | -85.4% | |
| Mar 15, 2023 | Rodriguez Javier87 | See Remarks | Sale+OE | 950 | $19.63 | $18,643.75 | -45.6% | +2.8% | -85.4% | |
| Jan 20, 2023 | Yocca Frank88 | Chief Scientific Officer | Sell | 50,000 | $30.00 | $1,500,000.00 | -85.6% | -30.2% | -91.5% |